Keywords: new, data, activase, gusto, trial, study, yielded

NEW DATA ON ACTIVASE FROM GUSTO TRIAL

Article | 29 November 1993

Print This

The GUSTO study has yielded up further data which suggests that Genentech's tissue plasminogen activator drug Activase is superior to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in